UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer

The New England journal of medicine, 2011-01, Vol.364 (3), p.205-214

2011

Link zum Volltext

Verfügbarkeit prüfen

Independent Adjudication of Symptomatic Heart Failure With the Use of Doxorubicin and Cyclophosphamide Followed by Trastuzumab Adjuvant Therapy: A Combined Review of Cardiac Data From the National Surgical Adjuvant Breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 Clinical Trials

Journal of clinical oncology, 2010-07, Vol.28 (21), p.3416-3421

2010

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1177-1183

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

Journal of clinical oncology, 2006-12, Vol.24 (34), p.5381-5387

2006

Link zum Volltext

Verfügbarkeit prüfen

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study

The lancet oncology, 2007-03, Vol.8 (3), p.203-211

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinico-radiologic features and management of hematological tumors in the breast: a case series

Breast cancer (Tokyo, Japan), 2019-03, Vol.26 (2), p.244-248

2019

Link zum Volltext

Verfügbarkeit prüfen

Carcinoma en cuirasse

Proceedings - Baylor University. Medical Center, 2019-04, Vol.32 (2), p.263-265

2019

Link zum Volltext

Verfügbarkeit prüfen

Two Cancers in One: Breast Carcinoma with Underlying Melanoma

Proceedings - Baylor University. Medical Center, 2017-07, Vol.30 (3), p.316-318

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II, Randomized, Double-Blind Study of Two Dose Levels of Arzoxifene in Patients With Locally Advanced or Metastatic Breast Cancer

Journal of clinical oncology, 2003-03, Vol.21 (6), p.1007-1014

2003

Link zum Volltext

Verfügbarkeit prüfen

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer

Cancer medicine (Malden, MA), 2018-06, Vol.7 (6), p.2288-2298

2018

Link zum Volltext

Verfügbarkeit prüfen

Our Experience as a Health Volunteers Overseas-Sponsored Team in Hué, Vietnam

Proceedings - Baylor University. Medical Center, 2013-04, Vol.26 (2), p.137-141

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Weekly Albumin-Bound Paclitaxel for Patients with Metastatic Breast Cancer Heavily Pretreated with Taxanes

Clinical breast cancer, 2007-12, Vol.7 (11), p.850-856

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Trastuzumab plus Gemcitabine in Chemotherapy-Pretreated Patients with Metastatic Breast Cancer

Clinical breast cancer, 2004-06, Vol.5 (2), p.142-147

2004

Link zum Volltext

Verfügbarkeit prüfen

A medical student perspective on solutions for burnout

Proceedings - Baylor University. Medical Center, 2019-07, Vol.32 (3), p.452-455

2019

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Breast Cancer: The Experience of Baylor University Medical Center at Dallas

Proceedings - Baylor University. Medical Center, 2011-04, Vol.24 (2), p.86-88

2011

Link zum Volltext

Verfügbarkeit prüfen

Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update

Breast cancer targets and therapy, 2011-10, Vol.3 (default), p.113-125

2011

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor-positive (ER+) metastatic breast cancer (MBC) patients (pts) with extreme responses (ERs) to capecitabine having tumors with genomic alterations in DNA repair and chromatin remodeling genes

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.555-555

2014

Link zum Volltext

Verfügbarkeit prüfen

ER as a predictor of early breast cancer (EBC) outcomes in patients

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.590-590

2013

Link zum Volltext

Verfügbarkeit prüfen

Burnout and career satisfaction among U.S. oncologists: Results of the 2012 ASCO survey

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.6533-6533

2013

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant capecitabine for invasive lobular/mixed early breast cancer (EBC): USON 01062 exploratory analyses

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.547-547

2012

Link zum Volltext

Verfügbarkeit prüfen

Carcinoma en cuirasse

Baylor University Medical Center Proceedings, 2019, Vol.32 (2), p.263-265

2019

Link zum Volltext

Verfügbarkeit prüfen

Carcinoma en cuirasse

Proceedings (Baylor University. Medical Center), 2019, Vol.32 (2), p.263-265

2019

Link zum Volltext

Verfügbarkeit prüfen

The coding audit

Annals of internal medicine, 1998-11, Vol.129 (9), p.755

Pippen, Jr, J E

1998

Link zum Volltext

Verfügbarkeit prüfen

Silicone Implants and Breast Cancer

Proceedings - Baylor University. Medical Center, 1995-07, Vol.8 (3), p.43-45

Pippen, John E.

1995

Link zum Volltext

Verfügbarkeit prüfen

Two cancers in one: breast carcinoma with underlying melanoma

Proceedings (Baylor University. Medical Center), 2017, Vol.30 (3), p.316-318

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(37)
Berichte
(3)

Sprache

Englisch
(40)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(18)
Oncology
(15)
Breast Neoplasms - Drug Therapy
(14)
Biological And Medical Sciences
(13)
Female
(13)
Adult
(12)
Medical Sciences
(12)
Middle Aged
(11)
Aged
(10)
Breast Cancer
(10)
Tumors
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Breast Neoplasms - Pathology
(8)
Chemotherapy
(6)
Breast Neoplasms - Mortality
(5)
Gynecology. Andrology. Obstetrics
(5)
Mammary Gland Diseases
(5)
Neoplasm Staging
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study

Clinico-radiologic features and management of hematological tumors in the breast: a case series

Carcinoma en cuirasse

Two Cancers in One: Breast Carcinoma with Underlying Melanoma

Phase II, Randomized, Double-Blind Study of Two Dose Levels of Arzoxifene in Patients With Locally Advanced or Metastatic Breast Cancer

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer

Our Experience as a Health Volunteers Overseas-Sponsored Team in Hué, Vietnam

Phase II Study of Weekly Albumin-Bound Paclitaxel for Patients with Metastatic Breast Cancer Heavily Pretreated with Taxanes

Phase II Study of Trastuzumab plus Gemcitabine in Chemotherapy-Pretreated Patients with Metastatic Breast Cancer

A medical student perspective on solutions for burnout

Inflammatory Breast Cancer: The Experience of Baylor University Medical Center at Dallas

Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update

Estrogen receptor-positive (ER+) metastatic breast cancer (MBC) patients (pts) with extreme responses (ERs) to capecitabine having tumors with genomic alterations in DNA repair and chromatin remodeling genes

ER as a predictor of early breast cancer (EBC) outcomes in patients

Burnout and career satisfaction among U.S. oncologists: Results of the 2012 ASCO survey

Adjuvant capecitabine for invasive lobular/mixed early breast cancer (EBC): USON 01062 exploratory analyses

Carcinoma en cuirasse

Carcinoma en cuirasse

The coding audit

Silicone Implants and Breast Cancer

Two cancers in one: breast carcinoma with underlying melanoma

Suchergebnisse filtern